The Pharma Letter
VIVEbiotech is a biotech company focused on gene therapy and genetic medicines, aiming to scale its business with global expansion and strategic leadership. It is involved in developing innovative treatments and has recently appointed Patricio Massera as president to steer its growth. The company is engaged in cutting-edge research in areas such as gene therapy for Parkinson’s disease and other genetic disorders, leveraging advancements in biotechnology and AI-driven drug discovery. VIVEbiotech is committed to advancing personalized medicine and innovative therapeutic solutions to address unmet medical needs worldwide.
Industries
Nr. of Employees
small (1-50)
The Pharma Letter
Products
Searchable digital content archive
A searchable repository of historical and current articles, podcasts and multimedia for research and reference.
Podcast episode archive
Indexed collection of past podcast episodes for on-demand listening and topical reference.
Company spotlight directory
Curated directory of featured start-ups and scale-ups with summaries and sector tags for discovery by investors and partners.
Special reports compilation
Collection of in-depth thematic special reports and feature analyses covering market trends, regulatory topics and therapeutic areas.
Searchable digital content archive
A searchable repository of historical and current articles, podcasts and multimedia for research and reference.
Podcast episode archive
Indexed collection of past podcast episodes for on-demand listening and topical reference.
Company spotlight directory
Curated directory of featured start-ups and scale-ups with summaries and sector tags for discovery by investors and partners.
Special reports compilation
Collection of in-depth thematic special reports and feature analyses covering market trends, regulatory topics and therapeutic areas.
Services
Timely production and online delivery of sector-specific news, short-form briefs and rapid summaries covering R&D, regulation and commercial activity.
Curated email roundups and subscription-managed delivery tailored to industry readers and topic preferences.
Commissioning, research and publication of long-form special reports and expert commentary on scientific, regulatory and market topics.
Production and distribution of podcast episodes featuring interviews with executives, scientists and analysts.
Conducting and publishing interviews and executive Q&As to provide primary-source insight on strategy, R&D and market positioning.
Editorial event calendar and listings with previews and coverage for industry conferences and meetings.
Timely production and online delivery of sector-specific news, short-form briefs and rapid summaries covering R&D, regulation and commercial activity.
Curated email roundups and subscription-managed delivery tailored to industry readers and topic preferences.
Commissioning, research and publication of long-form special reports and expert commentary on scientific, regulatory and market topics.
Production and distribution of podcast episodes featuring interviews with executives, scientists and analysts.
Conducting and publishing interviews and executive Q&As to provide primary-source insight on strategy, R&D and market positioning.
Editorial event calendar and listings with previews and coverage for industry conferences and meetings.
Expertise Areas
- Life-sciences sector journalism and daily news production
- Regulatory and clinical-trial reporting
- Data-driven investigative reporting (regulatory, patent, financial)
- Mergers & acquisitions and corporate finance coverage
Key Technologies
- Headless content management systems
- Cloud-based publishing platforms
- Personalization engines for content delivery
- Email newsletter distribution systems